Report
Mike Jeremy

Staying the course

First half FY 22 results mirrored the July trading update with revenue of £50.6m +14.5%YoY close to our revised estimate of £49.5m, and a closing order book at £62.6m (H1 21 £62.0m), which remained firm. Inflationary pressures and supply chain disruption remain features, however the Group continued to implement mitigating processes. We also note positive discussions with FREYR Battery towards a framework agreement for the installation of battery cell automation lines.

The underlying direction of travel for the markets Mpac targets remains unchanged. Spurred by the challenges of introducing environmentally friendly processes and packaging, and reducing plastic content and waste, Mpac’s target Healthcare and Food & Beverage verticals continue to require the innovative packaging and automation systems solutions in which the Group specialises. Mpac’s diversification into the new clean energy market provides a timely addition to the demand picture and offers the prospect of commercialised processes and solutions for wider application.

Our outlook, revised at the time of the July trading update, remains unchanged: for the current year: revenue of £96.0m, and EBITDA (adj.) of £6.1m, indicative of an EV/EBITDA multiple of 6.6x.

Our fair value for Mpac remains 485p/share, indicative of a FY24 EV/EBITDA multiple of 6.7x.
Underlying
Mpac Group

Mpac Group is focused on its Packaging Machinery business, Mpac Langen, which designs, precision engineers and manufactures packaging solutions, machinery and high specification automation, secondary packaging equipment and end-of-line robotics and at-line instrumentation and testing solutions as well as providing solutions including the design and integration of packaging systems.

Provider
Equity Development
Equity Development

​Equity Development enables companies to become better understood and supported by investors. Since our launch in 1996 we have consistently focused on helping our clients improve their communication and relationships with both existing and potential shareholders. Our clients have come from a wide variety of sectors and domiciles, are both private and quoted and range in size from micro-cap to $multi-billions. We offer free access to company research notes written by experienced analysts. These notes include detailed forecasts, financial models and a fair value. We host regular Private Investor Forums at which investors have the opportunity to hear company directors present, and to ask questions. These are free to attend. We broadcast live Webinars with company management that include active Q&A. We also make the recordings available online. We arrange face to face meetings between private investors and company management. We are active users of Twitter, commenting daily on company news, share price moves, Directors’ Dealings, Equity Development Research Notes & Events.

Analysts
Mike Jeremy

Other Reports on these Companies
Other Reports from Equity Development

ResearchPool Subscriptions

Get the most out of your insights

Get in touch